MENU

HIMS Stock Tickeron detected bearish Stock Pattern: Broadening Bottom HIMS on October 22, 2025, netting in a 20.95% gain over 3 weeks

A.I.dvisor
at Tickeron.com
Loading...
+20.95% Gain from a Successful pattern Broadening Bottom
HIMS - Hims & Hers Health
Tickeron
Ticker: HIMS
Company: Hims & Hers Health
Gain from shorting: +20.95%
Confirmed: 10/22/25
Succeeded: 11/12/25
Total length: 22 days

On October 21, 2025, A.I.dvisor detected a Broadening Bottom Pattern (Bearish) for Hims & Hers Health (HIMS, $49.36). 1 day later, on October 22, 2025, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On November 12, 2025, the stock hit the target price of $35.96 – resulting in a +2 gain for traders who shorted the stock on the pattern detection date.

HIMS sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for HIMS moved below the 200-day moving average on December 08, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where HIMS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on December 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HIMS as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HIMS entered a downward trend on December 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HIMS's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HIMS just turned positive on November 25, 2025. Looking at past instances where HIMS's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HIMS advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

HIMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HIMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.793) is normal, around the industry mean (19.578). P/E Ratio (71.264) is within average values for comparable stocks, (73.186). Projected Growth (PEG Ratio) (2.073) is also within normal values, averaging (1.942). HIMS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (4.333) is also within normal values, averaging (64.206).

View a ticker or compare two or three
HIMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HIMS showed earnings on November 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company, which is involved in real estate investment trusts

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
2269 Chestnut Street
Phone
+1 415 851-0195
Employees
658
Web
https://www.forhims.com